National Cancer Institute   U.S. National Institutes of Health | www.cancer.gov
Application Logo
Model Characteristics - Model: Prolactin induces ERα-positive and ERα-negative mammary cancer in Tg(Nrl-Prl)23Eps transgenic mice 
Model Descriptor Prolactin induces ERα-positive and ERα-negative mammary cancer in Tg(Nrl-Prl)23Eps transgenic mice
Official Nomenclature
Genotype
Species Mouse (Mus musculus)
Strain FVB/N 
Is This a Tool Strain? No
Developmental Stage
(applies only to Zebrafish)
 
Experimental Design The role of prolactin in human breast cancer has been controversial. However, it is now apparent that human mammary epithelial cells can synthesize prolactin endogenously, permitting autocrine/paracrine actions within the mammary gland that are independent of pituitary prolactin. To model this local mammary production of prolactin (PRL), we have generated mice that overexpress prolactin within mammary epithelial cells under the control of a hormonally nonresponsive promoter, neu-related lipocalin (NRL). In each of the two examined NRL-PRL transgenic mouse lineages, female virgin mice display mammary developmental abnormalities, mammary intraepithelial neoplasias, and invasive neoplasms. 
Phenotype Prolactin increases proliferation in morphologically normal alveoli and ducts, as well as in lesions. The tumors are of varied histotype, but papillary adenocarcinomas and adenosquamous neoplasms predominate. Neoplasms can be separated into two populations: one is estrogen receptor alpha (ERα) positive (greater than 15% of the cells stain for ERα), and the other is ERα−(<3%). ERα expression does not correlate with tumor histotype, or proliferative or apoptotic indices. These studies provide a mouse model of hormonally dependent breast cancer, and, perhaps most strikingly, a model in which some neoplasms retain ERα, as occurs in the human disease.
Website for add. info  
Breeding Notes

 

Sex Distribution of the Phenotype  
Submitted by caMOD, Curator
Principal Investigator / Lab Schuler, Linda A
Comment  
 
Model Availability: This model is available from
Strain Distributor Stock number
 
Comments Comments (Please login to submit new comments)
  CONTACT US     DISCLAIMER     ACCESSIBILITY     APPLICATION SUPPORT  
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov